Old Web
English
Sign In
Acemap
>
authorDetail
>
Prabhjot Singh Mundi
Prabhjot Singh Mundi
Columbia University
Medicine
Biology
Cancer
Protein kinase B
PI3K/AKT/mTOR pathway
4
Papers
139
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Identification and validation of a non-genetically encoded vulnerability to XPO1 inhibition in malignant rhabdoid tumors - expanding patient-driven discovery beyond the Nof1.
2021
bioRxiv
Lianna J. Marks
Daniel Diolaiti
Prabhjot Singh Mundi
Ervin Gaviria
Allison R. Rainey
Darrell J. Yamashiro
L. Fazlollahi
Hajime Hosoi
Y. Katsumi
Yasumichi Kuwahara
F.S. Dela Cruz
Andrea Califano
Andrew L. Kung
Show All
Source
Cite
Save
Citations (0)
Preclinical effect of selinexor (KPT-330), a selective inhibitor of nuclear export, in pediatric rhabdoid tumors.
2018
Journal of Clinical Oncology
Lianna J. Marks
Daniel Diolaiti
Prabhjot Singh Mundi
Ervin Gaviria
Allison Rainey
Filemon Dela Cruz
Andrea Califano
Andrew L. Kung
Show All
Source
Cite
Save
Citations (1)
Pediatric Sarcoma Data Forms a Unique Cluster Measured via the Earth Mover’s Distance
2017
Scientific Reports
Yongxin Chen
Filemon Dela Cruz
Romeil Sandhu
Andrew L. Kung
Prabhjot Singh Mundi
Joseph O. Deasy
Allen R. Tannenbaum
Show All
Source
Cite
Save
Citations (4)
AKT in cancer: new molecular insights and advances in drug development
2016
British Journal of Clinical Pharmacology
Prabhjot Singh Mundi
Jasgit C. Sachdev
Carolyn K. McCourt
Kevin Kalinsky
Show All
Source
Cite
Save
Citations (134)
1